The purpose of this review was to consider the Reappraisal of European guidelines on hypertension management published in 2009 in the light of 2005 French national guidelines and of recently published large randomized trials. We analyzed successively the recommendations dealing with assessment of global cardiovascular risk, hypertension treatment and blood pressure goals; we focused on patients at high cardiovascular risk: diabetic patients and patients with coronary disease and elderly population.